Today, Roche creates innovative medicines and diagnostic tests that help millions of patients globally. As a pioneer in healthcare, we have been committed to improving lives since the company was founded in 1896 in Basel, Switzerland.

Since our founding over 125 years ago, Roche has grown into one of the world’s largest biotech companies, as well as a leading provider of in-vitro diagnostics and a global supplier of transformative innovative solutions across major disease areas.

Roche is at the forefront of technological advancements in healthcare. Elevate your career with us by joining our tech team. Whether you're a software developer, data analyst, or IT expert, Roche provides a platform for you to innovate and make a lasting impact on global healthcare.

Roche’s momentum in digital pathology continues with FDA clearance on its high-volume slide scanner. The VENTANA DP 600 slide scanner, part of Roche’s Digital Pathology Dx system, is now cleared by the FDA to aid in clinical diagnosis, enabling pathologists to diagnose patients using digital images. Learn more

Roche Diagnostics develops innovative products and services that address the prevention, diagnosis, monitoring, screening and treatment of diseases.

Roche Pharmaceuticals is focused on translating excellence in science into effective medicines for patients. It combines cutting-edge research at in the US in Japan and over 250 partners worldwide with global scale and reach in clinical development, …

USA - Roche ... USA

The Roche Diagnostics digital service and support portal gives you instant access to important information at any time.

Jan 30, 2025 · Downloads Roche Group Pharmaceuticals pipeline Roche Group Diagnostics pipeline: key launches 2025 Roche Group Diagnostics pipeline: key launches 2024 Discover more Genentech Pipeline. This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible …

Zur deutschen Version. Healthcare is evolving, but our vision is clear. We are doing now what patients need next, focusing on preventing, stopping or altogether curing diseases with the highest societal burden in order to improve health outcomes and reduce costs for patients and healthcare systems around the world.